By Ken Rubenstein, Ph.D.

Published: November, 2002

350+ Pages, 20+ Exhibits, 57 Company Profiles 

Worldwide revenues for microbiotechnology (microarrays and microfluidics) are projected to reach $1.6 billion by 2006—29% growth for that year alone. 

Systems Integration Signals Shift in Biochips Market -- Combining the Power of Biochips, Instrumentation, and Reagents. 

Microbiotechnology is the field that applies small-scale parallelism and functional integration to the solution of bioanalytical problems. Stemming from its roots in both the semiconductor industry and the life sciences' instruments and reagents businesses, microbiotechnology is beginning to contribute to a renaissance in basic biological research. This transformation is based on Genome Era paradigms that are enabled by DNA and protein microarrays and, increasingly, by new applications of microfluidics. These technology platforms promise even greater rewards than early efforts of industrializing drug discovery by aiding in the detection of new targets and, even more importantly, new understandings of disease processes and useful points of intervention. 

D&MD's Market Analysis Report Biochip Technologies: Seizing New Opportunities in a Complex Market, provides an in-depth assessment of this multifaceted industry. 

Unique Benefits of this Report Include:

> Discover current and emerging technologies that are changing the shape of the fast-moving microarray and microfluidics markets via a thorough examination of their effects within biomedical research and development.

> Identify key technology deals of the past two years through a comprehensive review of their significance to the industry, including: DNA microarrays, protein microarrays, and microfluidics.

> Focus on the rewards of microbiotechnology through an in-depth discussion of existing and emerging products and applications, along with analysis of their relative impact and developing trends.

> Determine viable market opportunities from projections spanning across the microbiotechnology market—including the microfluidics, DNA microarrays, and protein microarrays segments.

> Keep your eye on the leading and rising companies within the microbiotechnology arena with extensive profiles of their financials, research and development, product pipelines, strategic alliances, intellectual property, detailed technology descriptions, and more. 

Now is the time to actively participate in microbiotechnology. This market promises to continue to evolve in terms of both revenue growth and realism in the choice of product targets. Strong investor interest during 1999 and 2000 has created a host of new start-ups with a diverse set of technologies within this sector. In addition, microbiotechnological solutions to biowarfare agent detection have gained increased support in recent months, and several products are now approaching commercialization.

Publisher: Drug and Market Development 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/DMD_2003.html#a243